SOURCE: DC Brands International, Inc.

April 19, 2006 16:05 ET

DC Brands International Announces 16oz. Low Carb Sugar Free to Hit the Docks Next Week

DENVER, CO -- (MARKET WIRE) -- April 19, 2006 -- At the close of business Tuesday, DC Brands International, Inc. (OTC: DCBI) announced that the long-anticipated 16oz. Low Carb Sugar Free product will be produced next Tuesday and start shipping out to distributors by week's end. The company's VP of Sales, Richard Muscarella, said, "The demand for this product is strong, especially so with the warmer weather of spring and summer we are now experiencing. You see a real difference as the weather changes and people start trying to drop those extra pounds from the colder months. We are sitting on three distributor orders already and we will be sending out sample product and data sheets to the rest of our distributor network next week. I expect some 3,000 cases of just this product to be sold before the end of May as we introduce it onto the retail shelves."

DC Brands International, Inc. markets its Dickens Energy Cider through a growing network of distributors nationwide. They intend for this new entry to the energy drink market to become a direct competitor to the market leaders Red Bull®, Monster®, and Rockstar®. However, they differentiate their drink with an additional ingredient, Horny Goat Weed, which adds a unique flavor that has won mouths over across the nation. As stated in previous press releases, DC Brands is also in the process of releasing their new "bag-in-the-box" and their alcohol versions of the product. (Please refer to those previous releases for more information.) The company's headquarters is located at 9500 W. 49th Ave, Wheat Ridge, CO, 80033. For more information on the company, visit their web site at Primary Contact: Keith Howard 303-279-3800

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information